Literature DB >> 7331777

Computerized visual field screening in the management of patients with ocular hypertension.

K Dyster-Aas, A Heijl, L Lundgvist.   

Abstract

Visual field testing which the Computer fully automatic computerized perimeter (Heijl & Krakau 1975) employing a supra-liminal screening test procedure was used in a material of 1013 eyes with ocular hypertension in which earlier routine perimetry (kinetic and static) on the Goldmann perimeter had yielded a normal result. The automatic screening was repeated if positive, and manual control perimetry was used in order to confirm or reject identified field defects. This procedure revealed field defects that could be confirmed at both automatic and manual perimetry in 3.6% of the eyes. In the control group the incidence of field defects found at manual perimetry during the same time interval was calculated at 0.4%. Thus automatic screening revealed several times more field defects than manual routine perimetry. Eyes in which repeated automatic screening had indicated defects which manual control perimetry failed to confirm, showed a high percentage of field loss at later follow-up. The results are discussed, and the conclusion is drawn that automatic screening is clearly superior to manual routine perimetry used at present. The most practical solution in many eye departments would be to use a computerized perimeter for the visual field screening of glaucoma suspects.

Entities:  

Mesh:

Year:  1980        PMID: 7331777     DOI: 10.1111/j.1755-3768.1980.tb08317.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  3 in total

1.  Performance of computer assisted perimeters.

Authors:  E L Greve
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

2.  Effect of retinal nerve fibre loss on the optic nerve head configuration in early glaucoma.

Authors:  P J Airaksinen; H I Alanko
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

3.  Observations on color vision testing in ocular hypertension and glaucoma.

Authors:  M Mäntyjärvi; M Teräsvirta
Journal:  Int Ophthalmol       Date:  1992-11       Impact factor: 2.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.